東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Accelerated path to cures

Bassaganya-Riera, Josep.

FindBook

Google Book

Amazon

博客來

Accelerated path to cures

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Accelerated path to cures/ edited by Josep Bassaganya-Riera.
其他作者:	Bassaganya-Riera, Josep.
出版者:	Cham :Springer International Publishing : : 2018.,
面頁冊數:	viii, 82 p. :ill., digital ;24 cm.
內容註:	Chapter 1: Introduction to Accelerated Path to Cures and Precision Medicine in Inflammatory Bowel Disease -- Chapter 2: Computer-Aided Drug Discovery -- Chapter 3: Preclinical Studies: Efficacy and Safety -- Chapter 4: From Nutritional Immunology to Drug Development -- Chapter 5: Development of Synthetic Patient Populations and In Silico Clinical Trials.
Contained By:	Springer eBooks
標題:	Immunology. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-73238-1
ISBN:	9783319732381

Accelerated path to cures
Accelerated path to cures[electronic resource] /edited by Josep Bassaganya-Riera. - Cham :Springer International Publishing :2018. - viii, 82 p. :ill., digital ;24 cm.

Chapter 1: Introduction to Accelerated Path to Cures and Precision Medicine in Inflammatory Bowel Disease -- Chapter 2: Computer-Aided Drug Discovery -- Chapter 3: Preclinical Studies: Efficacy and Safety -- Chapter 4: From Nutritional Immunology to Drug Development -- Chapter 5: Development of Synthetic Patient Populations and In Silico Clinical Trials.

Accelerated Path to Cures provides a transformative perspective on the power of combining advanced computational technologies, modeling, bioinformatics and machine learning approaches with nonclinical and clinical experimentation to accelerate drug development. This book discusses the application of advanced modeling technologies, from target identification and validation to nonclinical studies in animals to Phase 1-3 human clinical trials and post-approval monitoring, as alternative models of drug development. As a case of successful integration of computational modeling and drug development, we discuss the development of oral small molecule therapeutics for inflammatory bowel disease, from the application of docking studies to screening new chemical entities to the development of next-generation in silico human clinical trials from large-scale clinical data. Additionally, this book illustrates how modeling techniques, machine learning, and informatics can be utilized effectively at each stage of drug development to advance the progress towards predictive, preventive, personalized, precision medicine, and thus provide a successful framework for Path to Cures.

ISBN: 9783319732381

Standard No.: 10.1007/978-3-319-73238-1doiSubjects--Topical Terms:

611031
Immunology.

LC Class. No.: QR182.2.I46 / A234 2018

Dewey Class. No.: 616.0790285

Accelerated path to cures
LDR:02481nmm a2200313 a 4500 001 2141937
003 DE-He213
005 20181105164749.0
006 m d
007 cr nn 008maaau
008 181214s2018 gw s 0 eng d
020 $a 9783319732381 $q (electronic bk.)
020 $a 9783319732374 $q (paper)
024 7 $a 10.1007/978-3-319-73238-1 $2 doi
035 $a 978-3-319-73238-1
040 $a GP $c GP
041 0 $a eng
050 4 $a QR182.2.I46 $b A234 2018
072 7 $a MJCM $2 bicssc
072 7 $a MED044000 $2 bisacsh
082 0 4 $a 616.0790285 $2 23
090 $a QR182.2.I46 $b A169 2018
245 0 0 $a Accelerated path to cures $h [electronic resource] / $c edited by Josep Bassaganya-Riera.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a viii, 82 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1: Introduction to Accelerated Path to Cures and Precision Medicine in Inflammatory Bowel Disease -- Chapter 2: Computer-Aided Drug Discovery -- Chapter 3: Preclinical Studies: Efficacy and Safety -- Chapter 4: From Nutritional Immunology to Drug Development -- Chapter 5: Development of Synthetic Patient Populations and In Silico Clinical Trials.
520 $a Accelerated Path to Cures provides a transformative perspective on the power of combining advanced computational technologies, modeling, bioinformatics and machine learning approaches with nonclinical and clinical experimentation to accelerate drug development. This book discusses the application of advanced modeling technologies, from target identification and validation to nonclinical studies in animals to Phase 1-3 human clinical trials and post-approval monitoring, as alternative models of drug development. As a case of successful integration of computational modeling and drug development, we discuss the development of oral small molecule therapeutics for inflammatory bowel disease, from the application of docking studies to screening new chemical entities to the development of next-generation in silico human clinical trials from large-scale clinical data. Additionally, this book illustrates how modeling techniques, machine learning, and informatics can be utilized effectively at each stage of drug development to advance the progress towards predictive, preventive, personalized, precision medicine, and thus provide a successful framework for Path to Cures.
650 0 $a Immunology. $3 611031
650 0 $a Immunoinformatics. $3 1001463
650 0 $a Drug development. $3 716904
650 1 4 $a Biomedicine. $3 890831
650 2 4 $a Computational Biology/Bioinformatics. $3 898313
650 2 4 $a Health Informatics. $3 892928
650 2 4 $a Computer Appl. in Life Sciences. $3 892390
700 1 $a Bassaganya-Riera, Josep. $3 3321146
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-73238-1
950 $a Biomedical and Life Sciences (Springer-11642)